Skip to content

Therapy-related risk factors for second neoplasms after cancer in childhood - a population based nested case-control study (STATT - Second Tumour After Tumour Therapy, SCAR - Second Cancer After Radiotherapy)

Therapy-related risk factors for second neoplasms after cancer in childhood - a population based nested case-control study (STATT - Second Tumour After Tumour Therapy, SCAR - Second Cancer After Radiotherapy) - STATT-SCAR

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00017847
Enrollment
6220
Registered
2019-11-12
Start date
2015-09-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

second neoplasm according to classification: ICCC-3 (International Classification of Childhood Cancer): ICCC-3 groups I-XI

Interventions

Group 1: Cases: patients who had a neoplasm during childhood (under 15 years old) and who had another neoplasm 6 months or more later
all patients were registered at the German Childhood Cancer Registry (GCCR) between 1980 and 2014
Status of registry as of March 2016 Group 2: patients who had a neoplasm during childhood (under 15 years old) and who did not have another neoplasm at least until a neoplasm occurred in the correspon
Status of registry as of March 2016

Sponsors

Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 14 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria cohort: • GCCR registry dataset from 15 March 2016 • diagnosis of FPN and SPN included in ICCC-3 • FPN diagnosed between 1 January 1980 and 31 Dec 2014, age < 15 • recorded survival and follow-up of more than 6 months after FPN (365.25/2 days) • primary residency in Germany at time of diagnosis of FPN and SPN • due to latency period between FPN and SPN of at least 6 months (see below), technically the last date for FPN is 1 July 2014 Inclusion criteria cases: • SPN diagnosed between 1 January 1980 and 31 Dec 2014, any age • latency period (time between diagnosis of first and second neoplasm) at least 6 months (365.25/2 days) • due to latency period of at least 6 months, technically the last date for FPN is 1 July 2014 and first date for SPN is 2 July 1980

Exclusion criteria

Exclusion criteria: Exclusion criteria, study case: Study case: if the FN is in fact an SN or if the seemingly second neoplasm SPN is in fact the third neoplasm, which can occur in 5 situations: o before the FPN recorded at the GCCR, at least one neoplasm occurred abroad o before the FPN recorded at the GCCR, at least one neoplasm occurred before 1980 in West Germany or before 1991 in East Germany o before the FPN recorded at the GCCR, at least one neoplasm occurred which was not an ICCC-3 neoplasm o there was at least one neoplasm which was not an ICCC-3 neoplasm between the FPN and SPN or o before the FPN recorded at the GCCR, at least one neoplasm occurred which was not recorded as a case, but as an undated “pre-existing condition”, specifically pre-existing conditions with ICD10 D codes, ICD10 C codes or the codes E26.3 or L41.2. • Further decisions concerning SN based on further registry information about events and multiple neoplasms: o If the case recorded as SN is a transformation, a clonal diversity, a late event, or of unclear dignity. o An unverified and unverifiable subsequent case from an early period of the registry o Second neoplasm which had been collected by Dr. Gutjahr without verification or any additional information, only rough diagnosis etc. (details see Appendix 5) o If the diagnosis of SPN and FPN are identical at the ICCC3 extended level and (morphology is identical unless latency is more than five years). Exclusion criteria, study control: • if the potential control had a SPN before the SPN of the matching study case o which occurred abroad or o which was recorded, but not an ICCC-3 neoplasm (technically not an SPN) • if the FPN is in fact a SPN, which can have the following reasons: o before the FPN recorded at the GCCR, at least one neoplasm occurred abroad o before the FPN recorded at the GCCR, at least one neoplasm occurred before 1980 in West Germany or before 1991 in East Germany o before the FPN recorded at the GCCR, at least one neoplasm occurred which was not an ICCC-3 neoplasm or o before the FPN recorded at the GCCR, at least one neoplasm occurred which was not recorded as a case, but as an undated “pre-existing condition”, specifically pre-existing conditions with ICD10 D codes, ICD10 C codes or the codes E26.3 or L41.2. • case-by-case decision concerning a few problematic multiple tumors

Design outcomes

Primary

MeasureTime frame
second neoplasm 6 months or later after cancer at age <15 years; second neoplasm must have been diagnosed by 31 Dec 2014 and registered and validated at the German Childhood Cancer Registry by March 2016

Secondary

MeasureTime frame
specific second neoplasm 6 months or later after cancer at age <15 years; second neoplasm must have been diagnosed by 31 Dec 2014 and registered and validated at the German Childhood Cancer Registry by March 2016

Countries

Germany

Contacts

Public ContactClaudia Spix

Deutsches Kinderkrebsregister, Institut für Medizinische Biometrie, Epidemiologie und Informatik (IMBEI)Universitätsmedizin der Johannes Gutenberg-Universität Mainz

clauspix@uni-mainz.de06131 17 6852

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 10, 2026